PharmiWeb.com - Global Pharma News & Resources
04-Mar-2021

Transdermal Drug Delivery Systems Market Growth by New Techniques, Services and End User | Price and Porters Five Force Analysis by 2026

Transdermal drug delivery systems (TDDS) are also referred to as patches intend to deliver a dose of medicine on the patient skin and bloodstream. These patches promote faster healing of the wound and deliver a steady infusion of the drug over a time period. These patches are easy to use and penetrate slowly into the skin and are effective in treating deep wounds.

To learn more about this report, request a sample copy*
* The sample copy includes: Report Summary, Table of Contents, Segmentation, Competitive Landscape, Report Structure, Methodology.

Request a sample copy of this report@ https://www.coherentmarketinsights.com/insight/request-sample/689

Transdermal drug delivery systems are non-invasive, less painful, deliver the proper drug, and it can be removed easily anytime when therapy is not necessary. The main components of TDDS are a liner, drug, adhesive, membrane, blacking, matrix filler, and permeation enhancer. The types of TDDS includes single layer drug in adhesive, multi-layer drug in adhesive, reservoir, vapor, and matrix.

Advancement in the transdermal drug delivery system is projected to offer immense market growth in the near future. The advanced technology includes transdermal patch design modification, incorporation of pressure-sensitive adhesives and permeation enhancers that result in the enhancement of drug diffusion and increased the capacity to hold the drug in excess amount.

Market Taxonomy

By Application:

  • Neurological Disorders Pain Management
  • Hormone Replacement Therapy
  • Cardiovascular
  • Smoking Cessation
  • Contraception
  • Others

By Technology:

  • Electroporation
  • Electric current
  • Lontophoresis
  • Radio Frequency
  • Microporation
  • Thermal
  • Mechanical arrays
  • Ultrasound
  • Others

By Geography:

  • North America
  • Latin America
  • Europe
  • Asia Pacific
  • Middle East
  • Africa

Tailored Information as per niche requirement:
LIMITED TIME OFFER – Hurry Up!

Get Discount For Buyers UPTO 30% OFF On Any Research Report
Apply Promo Code “CMIFIRST1000” And Get an Instant Discount Of USD 1000
Buy Now This Premium Report to Grow your Business @ https://www.coherentmarketinsights.com/insight/buy-now/689

A growing number of surgical procedures across the globe and the rising prevalence of cardiovascular disorders is projected to further foster the transdermal drug delivery system market growth

North America and the Asia Pacific are expected to lead the highest growth in the transdermal drug delivery system market and this can be attributed to growth in the surgical procedures. As per the World Health Organization (WHO), the global surgical volume in 2012 was around 312.9 million. The cardiovascular disorders are expected to grow at an exponential stage during the forecast period, which can be attributed to an increase in the utilization of transdermal drug delivery systems. According to the American Heart Association, it was estimated that the incidence of a heart attack in the U.S. was around 58000 in 2014, and in 2013 worldwide prevalence of stroke was around 25.7 million. Also as per the World Health Organization (WHO), it was estimated that in 2015, around 17.7 million people died from cardiovascular diseases (CVDs) including around 31% of global deaths and among this, around 7.4% had coronary heart disease.

The growth in various types of diseases such as skin ulcers, acne, and skin rash leads to the exponential growth of surgical procedures and hence, this surgery’s growth can be attributed to growth in the utilization of transdermal drug delivery systems. As per the World Health Organization (WHO), the global surgical volume in 2012 was around 312.9 million, as the estimated mean global surgical rate was 4469 operations per 100 000 people every year.

Key Player:

Therapeutics Inc., ALLERGAN, Endo International plc, GlaxoSmithKline plc, Hisamitsu Pharmaceutical Co.Inc., IBSA Institut Biochimque SA, Mylan N.V., Pfizer, Inc., TEH SENG Pharmaceutical Mfg. Co., Ltd., and Teikoku Seiyaku Co., Ltd., 3M Pharmaceuticals Inc., Actelion Pharmaceuticals Ltd, Bayer Crop Science Ltd., BioGel Technology Inc., Upsher-Smith Laboratories, Inc., Johnson & Johnson Limited, Mylan Pharmaceuticals Inc., Novartis AG, Janssen Pharmaceuticals, Inc., Noven Pharmaceuticals Inc., Boehringer Ingelheim GmbH and Actavis Inc.

To understand Research Methodology, please click https://www.coherentmarketinsights.com/ongoing-insight/transdermal-drug-delivery-systems-market-689

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By End User
      • Market Snippet, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • PEST Analysis
  4. Global Transdermal Drug Delivery Systems – Impact of Coronavirus (Covid-19) Pandemic
    • COVID-19 Epidemiology
    • Safety Syringes for COIVD-19 Vaccines
  5. Global Transdermal Drug Delivery Systems Market, By Product Type, 2016 – 2027, (US$ Mn)
  6. Global Transdermal Drug Delivery Systems Market, By Application, 2016 – 2027, (US$ Mn)
  7. Global Transdermal Drug Delivery Systems Market, By End User, 2016 – 2027, (US$ Mn)
  8. Global Transdermal Drug Delivery Systems Market, By Region, 2016 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2020 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2027
    • North America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • U.S.
        • Canada
    • Latin America
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • Germany
        • U.K.
        • France
        • Italy
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • China
        • India
        • Japan
        • Australia
        • South Korea
        • ASEAN
        • Rest of Asia Pacific
    • Middle East
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country, 2016 – 2027, (US$ Mn)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By End User, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Country/Region, 2016 – 2027, (US$ Mn)
        • South Africa
        • Central Africa
        • North Africa
About Us:

Coherent Market Insights is a global market intelligence and consulting organization focused on assisting our plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, having office at global financial capital in the U.S. and sales consultants in United Kingdom and Japan. Our client base includes players from across various business verticals in over 150 countries worldwide. We pride ourselves in catering to clients across the length and width of the horizon, from Fortune 500 enlisted companies, to not-for-profit organization, and startups looking to establish a foothold in the market. We excel in offering unmatched actionable market intelligence across various industry verticals, including chemicals and materials, healthcare, and food & beverages, consumer goods, packaging, semiconductors, software and services, Telecom, and Automotive. We offer syndicated market intelligence reports, customized research solutions, and consulting services.

To know more about us, please visit our website – www.coherentmarketinsights.com

Contact:

Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837

Editor Details

  • Company:
    • CDN Newswire
Last Updated: 04-Mar-2021